Joseph Presti, MD, a urologist with The Permanente Medical Group, is an Adjunct Investigator with the Division of Research and a physician researcher with the Delivery Science & Applied Research Physician Researcher Program. Dr. Presti, who specializes in the evaluation and treatment of urologic cancers, has practiced at Kaiser Permanente Northern California (KPNC) since 2012. Previously, he held faculty positions at Stanford University and the University of California, San Francisco. Dr. Presti’s research focuses on refining detection strategies for prostate cancer. His early work investigated biopsy strategies for improving prostate cancer detection. He is now developing and evaluating a risk calculator that uses simple clinical variables to predict a patient’s risk of developing an aggressive prostate cancer. Dr. Presti also studies prostate cancer screening and detection, and he is currently working with the KPNC Department of Adult and Family Medicine to refine their shared decision-making program that aims to maximize benefits and minimize harms from prostate cancer screening. Dr. Presti serves as the co-clinical lead for the National KP Prostate Cancer Screening Guideline Team.
Current Position(s):
- Adjunct Investigator, Division of Research
- Physician Researcher, Delivery Science & Applied Research Physician Researcher Program, The Permanente Medical Group (TPMG)
- Regional Leader for Urologic Oncology Surgery, KPNC
Section Affiliations:
Primary Research Interests:
- Prostate cancer screening and detection
- Risk stratification for prostate cancer
